BG Medicine (BGMD) Names Stéphane Bancel Executive Chairman of the Board
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Join SI Premium – FREE
BG Medicine, Inc. (Nasdaq: BGMD) announced today that Stéphane Bancel, former CEO of bioMérieux (NYSE: BIM), has been appointed Executive Chairman of the Board of Directors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barksdale plans C$14M placement, name change, and leadership overhaul
- Agi names Rafael Siqueira as chief technology officer
- Scowtt names AdTech executive Ben Trenda as chief revenue officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
